¡Ya estamos en ! Descubre más

Nano X Imaging

NNOX

Capitalización de mercado USD 35.6 M

0.4529 USD

-0.0382

7.78%

Al cierre Actualizado 16 oct, 4:00 p.m. EDT

Antes de la apertura del mercado

Después del cierre del mercado

0.4295

-0.0234

5.17%

1 día

-7.78%

5 días

-17.65%

1 mes

-39.91%

3 meses

-56.45%

6 meses

-83.29%

En lo que va del año

-84%

1 año

-89.01%

5 años

-98.01%

10 años

-97.91%

Acerca de: Nano X Imaging Ltd is focused on driving the world's transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. The group combines affordable imaging hardware, progressive AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. The three segments are composed of the Nanox.ARC segment, the AI and software solutions segment, and the Radiology services segment. Key revenue is generated from Radiology Services.

Empleados: 197

Atención médica Dispositivos médicos

Noticias

Positivo

Neutral

Negativo

Sentimiento 3 meses

Positivo 0%

Neutral 100%

Negativo 0%

Nanox Provides Business Update and Furnishes Certain Preliminary Unaudited Financial Data for Third Quarter Ended September 30, 2026

PETACH TIKVA, Israel, Oct. 16, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today provided a brief business update and furnished certain preliminary unaudited financial data for the third quarter ended September 30, 2026. The preliminary figures are estimates based on currently available information, are preliminary and unaudited, and are subject to change upon completion of the Company's financial close process, final adjustments, management review and other internal procedures, and review by its independent auditors.

Nanox Provides Business Update and Furnishes Certain Preliminary Unaudited Financial Data for Third Quarter Ended September 30, 2026

Nanox AI Ltd. Enters into Distribution Agreement with Technologic s.r.l.

Agreement aims to expand the commercial reach of Nanox.AI's Bone Solution in the Italian healthcare market. Collaboration leverages Tecnologie Avanzate's 50 years of experience in the Italian medical technology market, established healthcare industry relationships, and expertise in introducing advanced medical technologies.

Nanox AI Ltd. Enters into Distribution Agreement with Technologic s.r.l.

Nanox Selected as One of TIME's Best Inventions of 2026 for its Nanox.ARC X

Nanox.ARC X recognized among the “world's most groundbreaking innovations” and for its approach to making advanced medical imaging more accessible

Nanox Selected as One of TIME's Best Inventions of 2026 for its Nanox.ARC X

Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica

Agreement with SOLME RC, SA Marks the third Latin American market this year PETACH TIKVA, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd.

Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica

Nano-X Imaging Ltd. (NNOX) Q2 2026 Earnings Call Transcript

Nano-X Imaging Ltd. (NNOX) Q2 2026 Earnings Call Transcript

Nano-X Imaging Ltd. (NNOX) Q2 2026 Earnings Call Transcript

Nano-X Imaging Q2 Earnings Call Highlights

Nano-X Imaging NASDAQ: NNOX reported second-quarter 2026 revenue growth driven by its teleradiology, health IT and AI businesses, while recording a substantial non-cash impairment charge and outlining cost-reduction actions intended to extend its cash runway.

Nano-X Imaging Q2 Earnings Call Highlights

Nanox Announces Second Quarter 2026 Financial Results and Provides Business Updates

PETACH TIKVA, Israel, Sept. 09, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the second quarter ended June 30, 2026, and provided a business update.

Nanox Announces Second Quarter 2026 Financial Results and Provides Business Updates

Nanox Signs Distribution Agreement with Associated X-Ray Imaging to Expand Nanox.ARC Adoption Across New England

Expands Nanox's growing U.S. distribution network with a leading New England-based medical imaging provider PETACH TIKVA, Israel — September 4 2026 — Nano-X Imaging Ltd. (“Nanox”, or the “Company”, NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced that its U.S.-based subsidiary, Nanox Impact Inc., has entered into a distribution agreement with Associated X-Ray Imaging Corp., a New England-based provider of medical imaging equipment and services, specializing in X-ray, MRI, and CT systems, to support deployment of the Nanox.ARC across the region.

Nanox Signs Distribution Agreement with Associated X-Ray Imaging to Expand Nanox.ARC Adoption Across New England

Nanox to Report Second Quarter 2026 Financial Results on September 9, 2026

PETACH TIKVA, Israel, Aug. 25, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended June 30, 2026, before market open on Monday, September, 9, 2026. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Guy Nathanzon, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.

Nanox to Report Second Quarter 2026 Financial Results on September 9, 2026

Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom

Initial three-year term includes minimum annual license commitments PETACH TIKVA, ISRAEL, August 18 2026 -- Nanox Imaging Ltd. (“ Nanox”, or the “Company” NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced its subsidiary, Nanox AI Ltd.

Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom

Ver rankings de noticias

Gráficos de precios implementados con Lightweight Charts™